Focus: Create Medicines is a public biotechnology company headquartered in Cambridge, MA, specializing in cell therapy for cancer with a workforce of 5,000+ employees. The company focuses on oncology, gene therapy, and cell therapy modalities.
Profile data last refreshed 20h ago · AI intelligence enriched 2w ago
No open roles listed right now. Follow Create Medicines to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Create Medicines
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Create Medicines's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Russian scientists discover how to use spruce in development of anticoagulant drugs - BelTA – News
Russian scientists discover how to use spruce in development of anticoagulant drugs BelTA – News
Q4 Earnings Outperformers: Vertex Pharmaceuticals (NASDAQ:VRTX) And The Rest Of The Therapeutics Stocks - The Globe and Mail
Q4 Earnings Outperformers: Vertex Pharmaceuticals (NASDAQ:VRTX) And The Rest Of The Therapeutics Stocks The Globe and Mail
Q4 Earnings Outperformers: Vertex Pharmaceuticals (NASDAQ:VRTX) And The Rest Of The Therapeutics Stocks - StockStory
Q4 Earnings Outperformers: Vertex Pharmaceuticals (NASDAQ:VRTX) And The Rest Of The Therapeutics Stocks StockStory
Scientists turn plastic waste into Parkinson's drug - edinburghinquirer.co.uk
Scientists turn plastic waste into Parkinson's drug edinburghinquirer.co.uk
Scientists make Parkinson’s drug from used plastic bottles - Times & Star
Scientists make Parkinson’s drug from used plastic bottles Times & Star
Scientists make Parkinson’s drug from used plastic bottles - Belfast Telegraph
Scientists make Parkinson’s drug from used plastic bottles Belfast Telegraph
Showing 6 of 10 news items
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
Optimization of a novel fermented kefir beverage fortified with Opuntia, Roselle, Chamomile, Marjoram, Honey and plant sugar using mixture and Box-Behnken design.
The Contributions of Multiple Polygenic Scores in Predicting Liability for Major Depressive Disorder and Its Comorbidity with Alcohol Use Disorder.
Showing 5 of 10 publications